Target intelligence / Profile preview

Host adaptive immune receptors (T-cell receptor and B-cell receptor) (TCR/BCR)

Target
TCR/BCR
Molecular classification
Receptor, Immunoglobulin superfamily, Glycoprotein
01

Overview

Host adaptive immune receptors, specifically T-cell receptors (TCRs) and B-cell receptors (BCRs), are the primary molecular components of the avian immune system that recognize antigens expressed by the Herpesvirus of Turkeys (HVT) vector [1]. HVT is a non-pathogenic alphaherpesvirus used globally as a live vaccine vector to deliver protective antigens from Marek’s Disease Virus (MDV) and other poultry pathogens [2]. These receptors function by binding to specific viral epitopes; BCRs recognize native protein structures to initiate antibody production, while TCRs recognize processed peptides presented by Major Histocompatibility Complex (MHC) molecules to trigger cellular immunity [3]. The interaction between these receptors and HVT-expressed antigens, such as glycoprotein B (gB), is critical for establishing protective immunity against Marek's Disease, a highly contagious lymphoproliferative disorder [4]. In the poultry industry, these receptors are the functional targets of recombinant HVT (rHVT) vaccines, which are engineered to elicit robust, lifelong protection without the virulence of wild-type MDV [5]. Understanding the specificity and activation thresholds of these receptors is essential for optimizing vaccine efficacy and overcoming challenges like maternal antibody interference [6].

Other names
T-cell receptorB-cell receptorAvian adaptive immune receptorsMarek's disease virus-specific receptorsChicken adaptive immune receptors
02

Mechanism of action

Activation of host T and B cells through the recognition of HVT-expressed viral antigens presented by MHC molecules, leading to protective immunity.

03

Biological functions

Immune responseAntigen recognitionCell-mediated immunityHumoral immunitySignal transduction
04

Disease associations

InfectionMarek's diseaseLymphoma
05

Safety considerations

Maternal antibody interferencePotential for viral recombinationImmunosuppression in compromised hostsDelayed onset of immunity in young chicks
06

Interacting drugs

Vaxxitek HVT+IBD

4 more in the full profile.

07

Biomarkers

Neutralizing antibody titers (ELISA/VN)Interferon-gamma (IFN-gamma) productionCD4+ and CD8+ T-lymphocyte countsAntigen-specific lymphocyte proliferation index

Beyond the preview

Go deeper on Host adaptive immune receptors (T-cell receptor and B-cell receptor) (TCR/BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host adaptive immune receptors (T-cell receptor and B-cell receptor) (TCR/BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call